(Q34721670)

4 August 2017

1 reference

title

Chemotherapy of lepromatous leprosy: recent developments and prospects for the future (English)

1 reference

4 August 2017

0 references

1 reference

1 reference

Gelber RH

1

1 reference

4 August 2017

publication date

1 November 1994

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

4 August 2017

published in

1 reference

4 August 2017

volume

13

1 reference

4 August 2017

issue

11

1 reference

4 August 2017

page(s)

942-952

1 reference

Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

Relapse following apparent arrest of leprosy by sulfone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

Effect of low-level and intermittent minocycline therapy on the growth of Mycobacterium leprae in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

In vitro and in vivo activities of macrolides against Mycobacterium leprae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

Clinical trial of clarithromycin for lepromatous leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111496

Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin

21 January 2018

1 reference

12 December 2020

Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review

1 reference

12 December 2020

The killing of Mycobacterium leprae in mice by various dietary concentrations of dapsone and rifampicin

1 reference

12 December 2020

Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates

1 reference

12 December 2020

Application of the thymectomized-irradiated mouse to the detection of persisting Mycobacterium leprae.

1 reference

12 December 2020

Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis

1 reference

12 December 2020

Two three-month treatment regimens for pulmonary tuberculosis

1 reference

12 December 2020

Activity of minocycline in Mycobacterium leprae-infected mice

1 reference

12 December 2020

A look at world leprosy

1 reference

12 December 2020

Dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat

1 reference

12 December 2020

Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.

1 reference

12 December 2020

Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.

1 reference

12 December 2020

In vitro and in vivo activities of ofloxacin against Mycobacterium leprae infection induced in mice

1 reference

12 December 2020

Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results

1 reference

12 December 2020

Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.

1 reference

12 December 2020

The killing of Mycobacterium leprae in mice by various dietary concentrations of clofazimine and ethionamide

1 reference

12 December 2020

Sulphone resistance in leprosy. A review of one hundred proven clinical cases

1 reference

12 December 2020

The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy

1 reference

12 December 2020

Effect of treatment on immune responsiveness in lepromatous leprosy patients

1 reference

12 December 2020

Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae

1 reference

12 December 2020

Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.

1 reference

12 December 2020

Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone

1 reference

12 December 2020

A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore

1 reference

12 December 2020

Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice

1 reference

12 December 2020

Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration

1 reference

12 December 2020

Ten Years of Dapsone in Lepromatous Leprosy: Clinical, Bacteriological and Histological Assessment and the Finding of Viable Leprosy Bacilli

1 reference

12 December 2020

THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICE.

1 reference

12 December 2020

Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.

1 reference

12 December 2020

Activity of ofloxacin against Mycobacterium leprae in the mouse

1 reference

12 December 2020

Drug resistance in leprosy--a review.

1 reference

12 December 2020

Clarithromycin at very low levels and on intermittent administration inhibits the growth of M. leprae in mice

1 reference

12 December 2020

Kinetic testing of drugs against Mycobacterium leprae in mice. Activity of cephaloridine, rifampin, streptovaricin, vadrine, and viomycin

1 reference

12 December 2020

Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid

1 reference

12 December 2020

Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse

1 reference

12 December 2020

Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long-term protection against M. leprae infection.

1 reference

12 December 2020

The in vitro action of antituberculous agents against multiplying and non-multiplying microbial cells

1 reference

12 December 2020

Search for effective short-course regimens for the treatment of leprosy.

1 reference

12 December 2020

A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.

1 reference

12 December 2020

Experimental and Clinical Studies on Rifampicin in Treatment of Leprosy

1 reference

12 December 2020

The bactericidal activity of various aminoglycoside antibiotics against Mycobacterium leprae in mice

1 reference

12 December 2020

A clinical trial of minocycline in lepromatous leprosy

1 reference

12 December 2020

Circulating T-cell numbers and their mitogenic potential in leprosy--correlation with mycobacterial load

1 reference

12 December 2020

The influence of antimycobacterial chemotherapy on delayed hypersensitivity skin-test reactions in leprosy patients

1 reference

12 December 2020

The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice

1 reference

12 December 2020

Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Trai

1 reference

12 December 2020

Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice

1 reference

12 December 2020

Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy

1 reference

12 December 2020

Rapid Bactericidal Effect of Rifampin on Mycobacterium Leprae *

1 reference

12 December 2020

Detection of persisting Mycobacterium leprae by inoculation of the neonatally thymectomized rat.

1 reference

12 December 2020

Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro

1 reference

12 December 2020

Relapse of leprosy in American Samoa

1 reference

12 December 2020

Activity of rifampin in infections of normal mice with Mycobacterium leprae

1 reference

12 December 2020

Rifampicin for lepromatous leprosy: nine years' experience

1 reference

12 December 2020

Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages

1 reference

12 December 2020

Combinations of drugs against Mycobacterium leprae studied in mice

1 reference

12 December 2020

Studies on the development of novel anti-leprous chemotherapeutics using nude mice with special reference to a new quinolone carboxylic acid, AT-4140.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02111496

1 reference

Dimensions Publication ID

4 August 2017

1004204181

0 references

1 reference